BioCentury
ARTICLE | Financial News

Immunex meets Street EPS

July 18, 2001 7:00 AM UTC

IMNX met the Street's EPS consensus of $0.07 for the second quarter. The $0.07 EPS figure excludes a $0.02 after-tax gain related to divestiture of certain non-core, generic products. The company said...